Interleukin 7 plays a role in T lymphocyte apoptosis inhibition driven by mesenchymal stem cell without favoring proliferation and cytokines secretion

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Normanton, Marilia ^a,b   Alvarenga, Heliene ^a,b   Hamerschlak, Nelson ^a   Ribeiro, Andreza ^a   Kondo, Andrea ^a   Rizzo, Luiz Vicente ^a   Marti, Luciana Cavalheiro ^a,b  

^a HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INDOMETACIN; INTERLEUKIN 17; INTERLEUKIN 7; INTERLEUKIN 7 RECEPTOR; PROSTAGLANDIN; CYTOKINE; IL7 PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; CD3+ T LYMPHOCYTE; CELL CONTACT; CELL SURVIVAL; COCULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPHOCYTE MEMBRANE; LYMPHOCYTE PROLIFERATION; MESENCHYMAL STEM CELL; PHARMACOLOGICAL BLOCKING; REGULATORY T LYMPHOCYTE; T CELL CULTURE; T LYMPHOCYTE; TH1 CELL; TH17 CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL TRACKING; GENETICS; MESENCHYMAL STROMA CELL; METABOLISM; PATHOLOGY; SECRETION (PROCESS);

APOPTOSIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL TRACKING; CYTOKINES; HUMANS; INTERLEUKIN-17; INTERLEUKIN-7; MESENCHYMAL STROMAL CELLS; RECEPTORS, INTERLEUKIN-7; T-LYMPHOCYTES; T-LYMPHOCYTES, REGULATORY; TH17 CELLS;

EID: 84906990872     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0106673     Document Type: Article

References (36)

1. Le Blanc K, Rasmusson I, Sundberg B, Götherström C, Hassan M, et al. (2004) Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet; 363(9419):1439-41.
2. Friedenstein AJ, Deriglasova UF, Kulagina NN, Panasuk AF, Rudakowa SF, et al. (1974) Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method. Experimental hematology; 2(2):83-92.
3. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, et al. (1999) Multilineage potential of adult human mesenchymal stem cells. Science; 284(5411):143-7.
4. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, et al. (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy; 8(4):315-7.
5. Prockop DJ (1997) Marrow stromal cells as stem cells for nonhematopoietic tissues. Science; 276(5309):71-4.
6. Beyer Nardi N and da Silva Meirelles L (2006) Mesenchymal stem cells: isolation, in vitro expansion and characterization. Handbook of experimental pharmacology; (174): 249-82.
7. Ding DC, Shyu WC, Lin SZ. (2011) Mesenchymal stem cells. Cell transplantation; 20(1):5-14.
8. Ren G, Su J, Zhang L, Zhao X, Ling W, et al. (2009) Species variation in the mechanisms of mesenchymal stem cell-mediated immunosuppression. Stem cells; 27(8):1954-62.
9. Bernardo ME and Fibbe WE (2013) Mesenchymal stromal cells: sensors and switchers of inflammation. Cell stem cell; 13(4):392-402.
10. Di Nicola M, Carlo-Stella C, Magni M, Milanesi M, Longoni PD, et al. (2002) Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood; 99(10):3838-43.
11. Meisel R, Zibert A, Laryea M, Gobel U, Daubener W, et al. (2004) Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2, 3-dioxygenase-mediated tryptophan degradation. Blood; 103(12):4619-21.
12. Aggarwal S and Pittenger MF (2005) Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood; 105(4):1815-22.
13. Krampera M, Glennie S, Dyson J, Scott D, Laylor R, et al. (2003) Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigenspecific T cells to their cognate peptide. Blood; 101(9):3722-9.
14. Sato K, Ozaki K, Oh I, Meguro A, Hatanaka K, et al. (2007) Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells. Blood; 109(1):228-34.
15. Mendez-Ferrer S, Michurina TV, Ferraro F, Mazloom AR, Macarthur BD, et al. (2010) Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature; 466(7308):829-34.
16. Rodriguez-Pardo VM and Vernot JP (2013) Mesenchymal stem cells promote a primitive phenotype CD34+c-kit+ in human cord blood-derived hematopoietic stem cells during ex vivo expansion. Cellular & molecular biology letters; 18(1):11-33.
17. Boomsma RA and Geenen DL (2012) Mesenchymal stem cells secrete multiple cytokines that promote angiogenesis and have contrasting effects on chemotaxis and apoptosis. PloS one; 7(4):e35685.
18. Tan JT, Dudl E, LeRoy E, Murray R, Sprent J, et al. (2001) IL-7 is critical for homeostatic proliferation and survival of naive T cells. Proceedings of the National Academy of Sciences of the United States of America; 98(15):8732-7.
19. Khaled AR and Durum SK (2002) Lymphocide: cytokines and the control of lymphoid homeostasis. Nature reviews. Immunology; 2(11):817-30.
20. Jacobs SR, Michalek RD, Rathmell JC (2010) IL-7 is essential for homeostatic control of T cell metabolism in vivo. J Immuno; 184(7):3461-9.
21. Normanton M and Marti LC (2013) Current data on IL-17 and Th17 cells and implications for graft versus host disease. Einstein; 11(2):237-46.
22. Deus GC, Normanton M, Hamerschlak N, Kondo AT, Ribeiro AA, et al. (2012) Isolation and characterization of mesenchymal stem cells obtained from reusable and disposable bone marrow collection filters. Einstein; 10(3):296-301.
23. Marti LC, Pavon L, Severino P, Sibov T, Guilhen D, et al. (2013) Vascular endothelial growth factor-A enhances indoleamine 2, 3-dioxygenase expression by dendritic cells and subsequently impacts lymphocyte proliferation. Mem Inst Oswaldo Cruz; 109(1):70-79.
24. Kim J and Hematti P (2009) Mesenchymal stem cell-educated macrophages: a novel type of alternatively activated macrophages. Experimental hematology; 37(12):1445-53.
25. Nemeth K, Leelahavanichkul A, Yuen PS, Mayer B, Parmelee A, et al. (2009) Bone marrow stromal cells attenuate sepsis via prostaglandin E (2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nature medicine; 15(1):42-9.
26. Meisel R, Zibert A, Laryea M, Gobel U, Daubener W, et al. (2004) Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2, 3-dioxygenase mediated tryptophan degradation. Blood; 103:4619-21.
27. Ryan JM, Barry F, Murphy JM, Mahon BP (2007) Interferon-gamma does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells. Clinical and experimental immunology; 149(2):353-63.
28. Francois M, Romieu-Mourez R, Li M, Galipeau J (2012) Human MSC suppression correlates with cytokine induction of indoleamine 2, 3-dioxygenase and bystander M2 macrophage differentiation. Molecular therapy: the journal of the American Society of Gene Therapy; 20(1):187-95.
29. Benvenuto F, Ferrari S, Gerdoni E, Gualandi F, Frassoni F, et al (2007) Human mesenchymal stem cells promote survival of T cells in a quiescent state. Stem cells; 25(7):1753-60.
30. Ramasamy R, Lam EW, Soeiro I, Tisato V, Bonnet D, et al. (2007) Mesenchymal stem cells inhibit proliferation and apoptosis of tumor cells: impact on in vivo tumor growth. Leukemia; 21(2):304-10.
31. Khubutiya MS, Vagabov AV, Temnov AA, Sklifas AN (2014) Paracrine mechanisms of proliferative, anti-apoptotic and anti-inflammatory effects of mesenchymal stromal cells in models of acute organ injury. Cytotherapy; 16(5):579-585.
32. Danial NN and Korsmeyer SJ (2004) Cell death: critical control points. Cell; 116(2):205-19.
33. Hofmeister R, Khaled AR, Benbernou N, Rajnavolgyi E, Muegge K, et al (1999) Interleukin-7: physiological roles and mechanisms of action. Cytokine Growth Factor Rev.; 10(1):41-60.
34. Al-Rawi MA, Mansel RE, Jiang WG (2003) Interleukin-7(IL-7) and IL-7 receptor (IL-7R) signalling complex in human solid tumours. Histology and histopathology; 18(3):911-23.
35. De Miguel MP, Fuentes-Julián S, Blázquez-Martínez A, Pascual CY, Aller MA, et al. (2012) Immunosuppressive properties of mesenchymal stem cells: advances and applications. Curr Mol Med.; 12(5):574-91.
36. Ghannam S, Pene J, Moquet-Torcy G, Jorgensen C, Yssel H (2013) Correction: mesenchymal stem cells inhibit human th17 cell differentiation and function and induce a T regulatory cell phenotype. Journal of immunology; 191(11):5777.